VKTX
Viking Therapeutics Inc
NASDAQ: VKTX · HEALTHCARE · BIOTECHNOLOGY
$30.00
-3.78% today
Updated 2026-05-01
Market cap
$3.63B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-3.19
Dividend yield
—
52W range
$23 – $43
Volume
2.4M
Viking Therapeutics Inc (VKTX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $10731.00 | $10701.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — | — | — | — | — | -0.3% | -100.0% | — | — | — |
| Cost of revenue | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $260000.00 | $277000.00 | $296000.00 | $291000.00 | $292000.00 | $346000.00 | $431000.00 |
| Gross profit | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-260000.00 | $10731.00 | $-296000.00 | $-291000.00 | $-292000.00 | $-346000.00 | $-431000.00 |
| Gross margin | — | — | — | — | — | — | — | — | 100.0% | -2766.1% | — | — | — | — |
| R&D | $275.00 | $11613.00 | $22.22M | $6.97M | $9.00M | $13.74M | $19.04M | $23.56M | $31.93M | $44.98M | $54.23M | $63.81M | $101.64M | $344.95M |
| SG&A | $163.00 | $89463.00 | $1.24M | $5.03M | $4.85M | $5.33M | $7.12M | $9.13M | $10.73M | $10.70M | $16.12M | $37.02M | $49.28M | $48.39M |
| Operating income | $-438.00 | $-101076.00 | $-23.47M | $-12.00M | $-13.85M | $-19.07M | $-26.16M | $-32.69M | $-42.66M | $-55.68M | $-70.36M | $-100.83M | $-150.92M | $-393.34M |
| Operating margin | — | — | — | — | — | — | — | — | -397558.5% | -520343.9% | — | — | — | — |
| EBITDA | $-109641.00 | $-121698.00 | $-21.26M | $-22.39M | $1.15M | $442882.00 | $4.66M | $-25.37M | $3.77M | $-55.39M | $-70.06M | $-100.83M | $-150.57M | $-393.34M |
| EBITDA margin | — | — | — | — | — | — | — | — | 35117.9% | -517577.8% | — | — | — | — |
| EBIT | $-110079.00 | $-101076.00 | $-23.47M | $-11.96M | $-12.70M | $-18.63M | $-21.50M | $-25.63M | $-39.49M | $-55.68M | $-70.36M | $-100.83M | $-150.92M | $-393.77M |
| Interest expense | — | $24549.00 | $628676.00 | $1.02M | $2.03M | $1.95M | $562000.00 | $146000.00 | $106000.00 | $18000.00 | $59000.00 | $88000.00 | $94000.00 | $56000.00 |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-444.00 | $-146247.00 | $-21.88M | $-23.40M | $-14.73M | $-20.58M | $-22.06M | $-25.78M | $-39.49M | $-54.99M | $-68.87M | $-85.89M | $-109.96M | $-359.64M |
| Net income growth (YoY) | — | -32838.5% | -14863.9% | -6.9% | +37.1% | -39.7% | -7.2% | -16.8% | -53.2% | -39.2% | -25.2% | -24.7% | -28.0% | -227.1% |
| Profit margin | — | — | — | — | — | — | — | — | -368045.8% | -513877.2% | — | — | — | — |